Clinical Trial Update: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Mino-Lok Therapy (MLT) targeting catheter-related bloodstream infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter-related Infections

Drugs mentioned

• Mino-Lok Therapy (MLT) (Mino-Lok Therapy)

Snippet

Sponsor: Leonard-Meron Biosciences, Inc. | Conditions: Catheter-related Infections | Phase 3 | Status: UNKNOWN